Loading…
Armata Pharmaceuticals, Inc. is projected to decline to $4.20 by 2027, a -7% move from its current price of $4.54. ARMP is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/3/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 4 | $4.27 | $4.54 | $4.82 | -0.03% |
| Aug 5 | $4.16 | $4.54 | $4.95 | -0.05% |
| Aug 6 | $4.08 | $4.54 | $5.04 | -0.08% |
| Aug 7 | $4.01 | $4.54 | $5.12 | -0.11% |
| Aug 8 | $3.96 | $4.53 | $5.20 | -0.13% |
| Aug 9 | $3.90 | $4.53 | $5.26 | -0.16% |
| Aug 10 | $3.86 | $4.53 | $5.32 | -0.19% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $3.86 | $4.53 | $5.32 | -0.19% |
| Week 2 | $3.60 | $4.52 | $5.68 | -0.37% |
| Week 3 | $3.41 | $4.51 | $5.97 | -0.56% |
| Week 4 | $3.26 | $4.51 | $6.22 | -0.75% |
| Week 5 | $3.14 | $4.50 | $6.45 | -0.93% |
| Week 6 | $3.02 | $4.49 | $6.66 | -1.12% |
| Week 7 | $2.92 | $4.48 | $6.87 | -1.30% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Armata Pharmaceuticals, Inc. is a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology.
Its product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA03 for Pseudomonas aeruginosa. The company is based in Los Angeles, California. Armata Pharmaceuticals, Inc. is a subsidiary of Innoviva, Inc.
Armata Pharmaceuticals, Inc. (ARMP) is a healthcare/biotechnology asset with a current price of $4.73 and a market cap of $173.64M.
Its rank is 3727 in market capitalization. This snapshot places the stock among smaller-cap biotechnology names in the healthcare sector.
The forecast suggests a near-term path around the current level with potential upside later in the horizon: the 2026 average price is $4.73 (min $3.76, max $6.81) and the 2031 average price is $6.86, with a long-run average of $19.77 by 2050 and a peak forecast of $45.47. The corresponding ROIs trend from 0 in 2026 to 45.1 in 2031, 43.6 in 2032, 76.2 in 2040, and 317.9 in 2050, indicating a shift to a bullish long-term outlook.
A major floor 64.9% below — a decisive break under it would weaken the trend.
The nearest floor, 17.2% below — buyers have tended to step in here.
The nearest ceiling, 63.0% above — a clean break opens room to run.
A major ceiling 226.0% above — clearing it would confirm fresh momentum.
Key ARMP support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ARMP market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $4.75 | Sell | $4.70 | Sell |
| MA 10 | $4.91 | Sell | $4.77 | Sell |
| MA 20 | $4.71 | Sell | $5.03 | Sell |
| MA 50 | $6.31 | Sell | $6.16 | Sell |
| MA 100 | $8.25 | Sell | $7.05 | Sell |
| MA 200 | $7.55 | Sell | $6.84 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 40.43 | Neutral |
| Stoch RSI (14) | 77.30 | Neutral |
| CCI (20) | -26.92 | Neutral |
| Williams %R (14) | -47.30 | Info |
| MACD (12,26,9) | 0.11 | Buy |
| ROC (12) | 13.78 | Buy |
| Bollinger %B (20,2) | 0.42 | Neutral |
| Stochastic %K (14) | 52.70 | Neutral |
| TRIX (15) | -1.43 | Sell |
| Awesome (5,34) | -0.82 | Sell |
| Ultimate (7,14,28) | 40.82 | Neutral |
| Momentum (10) | 0.03 | Buy |
| Aroon Osc (25) | -52.00 | Sell |
| Hull MA (9) | 4.55 | Sell |
| ADX (14) | 24.37 | Sell |
| ATR (14) | 0.31 | Info |
The 30-day technical picture isNeutral, with RSI14 at 40.
The 50-day simple moving average (SMA) is $6.67 and the 200-day SMA is $7.51, signaling a price pattern below both short- and long-term moving averages.
Support is at $3.76 and resistance at $7.58. The 30-day price range spans from a low of $3.21 to a high of $6.97.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $3.76 | $4.54 | $6.51 | 0% | Neutral | |
| $3.06 | $4.20 | $6.23 | -7% | Neutral | |
| $2.94 | $4.30 | $6.80 | -5% | Neutral | |
| $2.64 | $4.06 | $6.74 | -11% | Neutral | |
| $2.77 | $4.46 | $7.73 | -2% | Neutral | |
| $3.91 | $6.59 | $11.82 | +45% | Bullish | |
| $3.77 | $6.62 | $12.25 | +46% | Bullish | |
| $3.21 | $5.87 | $11.16 | +29% | Bullish | |
| $3.05 | $5.82 | $11.34 | +28% | Bullish | |
| $2.86 | $5.66 | $11.29 | +25% | Bullish | |
| $3.62 | $8.06 | $17.67 | +77% | Bullish | |
| $8.73 | $19.40 | $44.62 | +327% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $3.76 | $4.54 | $5.86 | +0.00% |
| September 2026 | $3.83 | $4.66 | $5.91 | +2.55% |
| October 2026 | $3.59 | $4.43 | $5.74 | -4.84% |
| November 2026 | $3.69 | $4.61 | $6.06 | +3.96% |
| December 2026 | $3.87 | $4.88 | $6.51 | +5.89% |
Click any year to see its month-by-month ARMP forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The ARMP price prediction for 2026 points to an average of $4.54 (low $3.76, high $6.51) — a potential gain of 0% on today's $4.54. A consolidation phase looks the most probable path here.
In 2027, ARMP is projected to trade between $3.06 and $6.23, averaging $4.20 — a potential decline of -7% from today's $4.54. That is -7% versus the projected 2026 average. Price action looks broadly range-bound.
Armata Pharmaceuticals, Inc.'s 2028 outlook centres on $4.30, within a $2.94 to $6.80 range. That is up +2% on the projected 2027 average. That marks a -5% change versus current levels. A consolidation phase looks the most probable path here.
By 2029, ARMP could reach as high as $6.74, with a base case around $4.06 and support toward $2.64 — roughly -11% from $4.54. Price action looks broadly range-bound.
Expect ARMP to range from $2.77 to $7.73 through 2030. The $4.46 average target implies a -2% move from current prices. That is up +10% on the projected 2029 average. A consolidation phase looks the most probable path here.
The ARMP price prediction for 2031 points to an average of $6.59 (low $3.91, high $11.82) — a potential gain of +45% on today's $4.54. Momentum favours further upside here.
In 2032, ARMP is projected to trade between $3.77 and $12.25, averaging $6.62 — a potential gain of +46% from today's $4.54. That is up 0% on the projected 2031 average. Buyers look set to stay in control over this stretch.
Armata Pharmaceuticals, Inc.'s 2033 outlook centres on $5.87, within a $3.21 to $11.16 range. That is -11% versus the projected 2032 average. That marks a +29% change versus current levels. Momentum favours further upside here.
By 2034, ARMP could reach as high as $11.34, with a base case around $5.82 and support toward $3.05 — roughly +28% from $4.54. Buyers look set to stay in control over this stretch.
Expect ARMP to range from $2.86 to $11.29 through 2035. The $5.66 average target implies a +25% move from current prices. That is -3% versus the projected 2034 average. Momentum favours further upside here.
The ARMP price prediction for 2040 points to an average of $8.06 (low $3.62, high $17.67) — a potential gain of +77% on today's $4.54. Buyers look set to stay in control over this stretch.
In 2050, ARMP is projected to trade between $8.73 and $44.62, averaging $19.40 — a potential gain of +327% from today's $4.54. That is up +141% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in ARMP today (≈ 220.264317 ARMP) could be worth
$4,273.06
+$3,273.06 (+327%) by 2050 · US Dollar
Based on the average projected ARMP price of $19.4 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ARMPwould be worth at today's price.
$1,000 invested in ARMP on Jul 31, 2025 (≈ 408.163257 ARMP) would be worth
$1,853.06
+$853.06 (+85.3%) today · 1.85× · US Dollar
Based on a ARMP entry price of $2.45 vs. today's $4.54.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $4.66 | $974.25 | -2.6% |
| 1 month ago | $5.88 | $772.11 | -22.8% |
| 3 months ago | $8.89 | $510.69 | -48.9% |
| 6 months ago | $7.74 | $586.56 | -41.3% |
| 1 year ago | $2.45 | $1,853.06 | +85.3% |
| All time (5.0y) ago | $3.88 | $1,170.1 | +17.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ARMP forecast.
Our base-case forecast reaches $9.10 around 2050.
Implied market cap at $9.10: $334.07M
The multi-year forecast shows a near-term path that stays around current levels through 2026-2030 (2026 avg $4.73; min $3.76; max $6.81; ROI 0; sentiment NEUTRAL; 2027 avg $4.34; max $6.44; min $3.16; ROI -8.3; 2028 avg $4.48; max $7.10; min $3.07; ROI -5.3; 2029 avg $4.18; max $6.96; min $2.72; ROI -11.6; 2030 avg $4.57; max $7.92; min $2.83; ROI -3.3).
From 2031 onward, the forecast turns bullish, with 2031 avg $6.86 (ROI 45.1) and 2032 avg $6.79 (ROI 43.6), followed by 2033 avg $5.97 (ROI 26.2), 2034 avg $6.08 (ROI 28.6), and 2035 avg $5.80 (ROI 22.6).
Longer-horizon upside is strong, with 2040 avg $8.33 (ROI 76.2) and 2050 avg $19.77 (ROI 317.9). The bullish tone in the later years comes with higher potential returns, but these are estimates and not guarantees. Investors should consider the mix of near-term volatility with a pronounced longer-term upside in the forecast.
Tap a question to reveal the answer.
The forecast shows min $2.83, avg $4.57, max $7.92; ROI -3.3; sentiment NEUTRAL.
Near-term projections (2026: avg $4.73; ROI 0; sentiment NEUTRAL) and a longer-term bullish outlook from 2031 onward (2031 avg $6.86; 2050 avg $19.77; ROI 45.1 to 317.9) suggest potential upside, but these are estimates, not guarantees.
Yes, the forecast max values reach $18.28 in 2040 and $45.47 in 2050, so surpassing $15 by 2040 at the latest.
From 2031 onward the forecast shows bullish sentiment, with 2031 avg 6.86, 2032 6.79, 2040 8.33, 2050 19.77; ROI values of 45.1, 43.6, 76.2, and 317.9 correspond to those years.
2026 avg 4.73; 2027 avg 4.34; 2028 avg 4.48; 2029 avg 4.18; 2030 avg 4.57; ROIs: 0, -8.3, -5.3, -11.6, -3.3.
Armata Pharmaceuticals, Inc. Community Discussion
0Share your Armata Pharmaceuticals, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.